nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—PRKG2—smooth muscle tissue—peritoneum cancer	0.0168	0.0168	CbGeAlD
Ruxolitinib—PLK1—uterus—peritoneum cancer	0.0129	0.0129	CbGeAlD
Ruxolitinib—PLK3—decidua—peritoneum cancer	0.0123	0.0123	CbGeAlD
Ruxolitinib—PLK1—lymphoid tissue—peritoneum cancer	0.012	0.012	CbGeAlD
Ruxolitinib—PLK3—endometrium—peritoneum cancer	0.0117	0.0117	CbGeAlD
Ruxolitinib—CAMK1—decidua—peritoneum cancer	0.0115	0.0115	CbGeAlD
Ruxolitinib—CAMK1—endometrium—peritoneum cancer	0.0109	0.0109	CbGeAlD
Ruxolitinib—JAK1—epithelium—peritoneum cancer	0.01	0.01	CbGeAlD
Ruxolitinib—PRKG2—liver—peritoneum cancer	0.00986	0.00986	CbGeAlD
Ruxolitinib—JAK1—smooth muscle tissue—peritoneum cancer	0.00963	0.00963	CbGeAlD
Ruxolitinib—JAK1—decidua—peritoneum cancer	0.00944	0.00944	CbGeAlD
Ruxolitinib—PRKCE—liver—peritoneum cancer	0.00921	0.00921	CbGeAlD
Ruxolitinib—JAK1—endometrium—peritoneum cancer	0.00896	0.00896	CbGeAlD
Ruxolitinib—PLK1—liver—peritoneum cancer	0.00885	0.00885	CbGeAlD
Ruxolitinib—RPS6KA6—liver—peritoneum cancer	0.00885	0.00885	CbGeAlD
Ruxolitinib—PLK3—female gonad—peritoneum cancer	0.00881	0.00881	CbGeAlD
Ruxolitinib—DAPK3—smooth muscle tissue—peritoneum cancer	0.00864	0.00864	CbGeAlD
Ruxolitinib—ROCK1—epithelium—peritoneum cancer	0.00861	0.00861	CbGeAlD
Ruxolitinib—DAPK2—endometrium—peritoneum cancer	0.00855	0.00855	CbGeAlD
Ruxolitinib—DAPK3—decidua—peritoneum cancer	0.00847	0.00847	CbGeAlD
Ruxolitinib—CLK2—decidua—peritoneum cancer	0.00839	0.00839	CbGeAlD
Ruxolitinib—ROCK1—smooth muscle tissue—peritoneum cancer	0.00829	0.00829	CbGeAlD
Ruxolitinib—JAK1—uterus—peritoneum cancer	0.00826	0.00826	CbGeAlD
Ruxolitinib—DCLK1—uterus—peritoneum cancer	0.00826	0.00826	CbGeAlD
Ruxolitinib—CAMK1—female gonad—peritoneum cancer	0.00824	0.00824	CbGeAlD
Ruxolitinib—BMPR2—smooth muscle tissue—peritoneum cancer	0.00806	0.00806	CbGeAlD
Ruxolitinib—DAPK3—endometrium—peritoneum cancer	0.00804	0.00804	CbGeAlD
Ruxolitinib—CLK2—endometrium—peritoneum cancer	0.00796	0.00796	CbGeAlD
Ruxolitinib—DYRK1A—decidua—peritoneum cancer	0.00793	0.00793	CbGeAlD
Ruxolitinib—BMPR2—decidua—peritoneum cancer	0.0079	0.0079	CbGeAlD
Ruxolitinib—JAK3—lymphoid tissue—peritoneum cancer	0.00775	0.00775	CbGeAlD
Ruxolitinib—JAK1—lymphoid tissue—peritoneum cancer	0.0077	0.0077	CbGeAlD
Ruxolitinib—PLK4—lymphoid tissue—peritoneum cancer	0.00765	0.00765	CbGeAlD
Ruxolitinib—NUAK2—decidua—peritoneum cancer	0.00755	0.00755	CbGeAlD
Ruxolitinib—DAPK3—uterus—peritoneum cancer	0.00741	0.00741	CbGeAlD
Ruxolitinib—TAOK2—female gonad—peritoneum cancer	0.0074	0.0074	CbGeAlD
Ruxolitinib—PLK3—liver—peritoneum cancer	0.00738	0.00738	CbGeAlD
Ruxolitinib—STK16—lymphoid tissue—peritoneum cancer	0.00723	0.00723	CbGeAlD
Ruxolitinib—HIPK2—lymphoid tissue—peritoneum cancer	0.00719	0.00719	CbGeAlD
Ruxolitinib—NUAK2—endometrium—peritoneum cancer	0.00717	0.00717	CbGeAlD
Ruxolitinib—BMP2K—decidua—peritoneum cancer	0.00707	0.00707	CbGeAlD
Ruxolitinib—PRKCE—lymph node—peritoneum cancer	0.00706	0.00706	CbGeAlD
Ruxolitinib—LRRK2—decidua—peritoneum cancer	0.00701	0.00701	CbGeAlD
Ruxolitinib—BMPR2—uterus—peritoneum cancer	0.00691	0.00691	CbGeAlD
Ruxolitinib—CAMK1—liver—peritoneum cancer	0.00691	0.00691	CbGeAlD
Ruxolitinib—CLK2—lymphoid tissue—peritoneum cancer	0.00684	0.00684	CbGeAlD
Ruxolitinib—JAK3—female gonad—peritoneum cancer	0.0068	0.0068	CbGeAlD
Ruxolitinib—PLK1—lymph node—peritoneum cancer	0.00678	0.00678	CbGeAlD
Ruxolitinib—RPS6KA6—lymph node—peritoneum cancer	0.00678	0.00678	CbGeAlD
Ruxolitinib—JAK1—female gonad—peritoneum cancer	0.00676	0.00676	CbGeAlD
Ruxolitinib—BMP2K—endometrium—peritoneum cancer	0.00671	0.00671	CbGeAlD
Ruxolitinib—CAMK2G—endometrium—peritoneum cancer	0.00671	0.00671	CbGeAlD
Ruxolitinib—LRRK2—endometrium—peritoneum cancer	0.00665	0.00665	CbGeAlD
Ruxolitinib—ROCK1—lymphoid tissue—peritoneum cancer	0.00663	0.00663	CbGeAlD
Ruxolitinib—CAMK1D—female gonad—peritoneum cancer	0.00659	0.00659	CbGeAlD
Ruxolitinib—PHKG2—female gonad—peritoneum cancer	0.00656	0.00656	CbGeAlD
Ruxolitinib—MKNK2—epithelium—peritoneum cancer	0.00652	0.00652	CbGeAlD
Ruxolitinib—MAP3K7—smooth muscle tissue—peritoneum cancer	0.00649	0.00649	CbGeAlD
Ruxolitinib—DYRK1A—lymphoid tissue—peritoneum cancer	0.00647	0.00647	CbGeAlD
Ruxolitinib—DAPK2—female gonad—peritoneum cancer	0.00645	0.00645	CbGeAlD
Ruxolitinib—BMPR2—lymphoid tissue—peritoneum cancer	0.00644	0.00644	CbGeAlD
Ruxolitinib—TYK2—smooth muscle tissue—peritoneum cancer	0.00637	0.00637	CbGeAlD
Ruxolitinib—RET—epithelium—peritoneum cancer	0.00636	0.00636	CbGeAlD
Ruxolitinib—MAP3K7—decidua—peritoneum cancer	0.00636	0.00636	CbGeAlD
Ruxolitinib—STK16—female gonad—peritoneum cancer	0.00634	0.00634	CbGeAlD
Ruxolitinib—HIPK2—female gonad—peritoneum cancer	0.00631	0.00631	CbGeAlD
Ruxolitinib—MKNK2—smooth muscle tissue—peritoneum cancer	0.00629	0.00629	CbGeAlD
Ruxolitinib—IRAK1—smooth muscle tissue—peritoneum cancer	0.00629	0.00629	CbGeAlD
Ruxolitinib—TYK2—decidua—peritoneum cancer	0.00624	0.00624	CbGeAlD
Ruxolitinib—TAOK2—liver—peritoneum cancer	0.0062	0.0062	CbGeAlD
Ruxolitinib—CAMK2G—uterus—peritoneum cancer	0.00618	0.00618	CbGeAlD
Ruxolitinib—MKNK2—decidua—peritoneum cancer	0.00616	0.00616	CbGeAlD
Ruxolitinib—IRAK1—decidua—peritoneum cancer	0.00616	0.00616	CbGeAlD
Ruxolitinib—DAPK3—female gonad—peritoneum cancer	0.00606	0.00606	CbGeAlD
Ruxolitinib—MAP3K7—endometrium—peritoneum cancer	0.00604	0.00604	CbGeAlD
Ruxolitinib—JAK2—epithelium—peritoneum cancer	0.00601	0.00601	CbGeAlD
Ruxolitinib—RET—decidua—peritoneum cancer	0.00601	0.00601	CbGeAlD
Ruxolitinib—CLK2—female gonad—peritoneum cancer	0.006	0.006	CbGeAlD
Ruxolitinib—TYK2—endometrium—peritoneum cancer	0.00593	0.00593	CbGeAlD
Ruxolitinib—MKNK2—endometrium—peritoneum cancer	0.00585	0.00585	CbGeAlD
Ruxolitinib—ROCK1—female gonad—peritoneum cancer	0.00582	0.00582	CbGeAlD
Ruxolitinib—JAK2—smooth muscle tissue—peritoneum cancer	0.00579	0.00579	CbGeAlD
Ruxolitinib—JAK2—decidua—peritoneum cancer	0.00568	0.00568	CbGeAlD
Ruxolitinib—DYRK1A—female gonad—peritoneum cancer	0.00567	0.00567	CbGeAlD
Ruxolitinib—JAK1—liver—peritoneum cancer	0.00567	0.00567	CbGeAlD
Ruxolitinib—PLK3—lymph node—peritoneum cancer	0.00566	0.00566	CbGeAlD
Ruxolitinib—BMPR2—female gonad—peritoneum cancer	0.00565	0.00565	CbGeAlD
Ruxolitinib—MAP3K2—uterus—peritoneum cancer	0.00561	0.00561	CbGeAlD
Ruxolitinib—MAP3K7—uterus—peritoneum cancer	0.00556	0.00556	CbGeAlD
Ruxolitinib—CAMK1D—liver—peritoneum cancer	0.00553	0.00553	CbGeAlD
Ruxolitinib—PHKG2—liver—peritoneum cancer	0.0055	0.0055	CbGeAlD
Ruxolitinib—MAP3K3—decidua—peritoneum cancer	0.00547	0.00547	CbGeAlD
Ruxolitinib—LTK—lymph node—peritoneum cancer	0.00547	0.00547	CbGeAlD
Ruxolitinib—TYK2—uterus—peritoneum cancer	0.00546	0.00546	CbGeAlD
Ruxolitinib—NUAK2—female gonad—peritoneum cancer	0.0054	0.0054	CbGeAlD
Ruxolitinib—JAK2—endometrium—peritoneum cancer	0.00539	0.00539	CbGeAlD
Ruxolitinib—MKNK2—uterus—peritoneum cancer	0.00539	0.00539	CbGeAlD
Ruxolitinib—STK16—liver—peritoneum cancer	0.00532	0.00532	CbGeAlD
Ruxolitinib—CAMK1—lymph node—peritoneum cancer	0.0053	0.0053	CbGeAlD
Ruxolitinib—HIPK2—liver—peritoneum cancer	0.00529	0.00529	CbGeAlD
Ruxolitinib—MAP3K2—lymphoid tissue—peritoneum cancer	0.00523	0.00523	CbGeAlD
Ruxolitinib—MAP3K3—endometrium—peritoneum cancer	0.0052	0.0052	CbGeAlD
Ruxolitinib—MARK2—lymph node—peritoneum cancer	0.00514	0.00514	CbGeAlD
Ruxolitinib—TYK2—lymphoid tissue—peritoneum cancer	0.00509	0.00509	CbGeAlD
Ruxolitinib—DAPK3—liver—peritoneum cancer	0.00508	0.00508	CbGeAlD
Ruxolitinib—CAMK2G—female gonad—peritoneum cancer	0.00506	0.00506	CbGeAlD
Ruxolitinib—BMP2K—female gonad—peritoneum cancer	0.00506	0.00506	CbGeAlD
Ruxolitinib—CLK2—liver—peritoneum cancer	0.00503	0.00503	CbGeAlD
Ruxolitinib—MKNK2—lymphoid tissue—peritoneum cancer	0.00502	0.00502	CbGeAlD
Ruxolitinib—LRRK2—female gonad—peritoneum cancer	0.00501	0.00501	CbGeAlD
Ruxolitinib—TAOK3—decidua—peritoneum cancer	0.00499	0.00499	CbGeAlD
Ruxolitinib—RET—lymphoid tissue—peritoneum cancer	0.0049	0.0049	CbGeAlD
Ruxolitinib—ROCK1—liver—peritoneum cancer	0.00488	0.00488	CbGeAlD
Ruxolitinib—DYRK1A—liver—peritoneum cancer	0.00476	0.00476	CbGeAlD
Ruxolitinib—TAOK2—lymph node—peritoneum cancer	0.00476	0.00476	CbGeAlD
Ruxolitinib—BMPR2—liver—peritoneum cancer	0.00474	0.00474	CbGeAlD
Ruxolitinib—TAOK3—endometrium—peritoneum cancer	0.00474	0.00474	CbGeAlD
Ruxolitinib—JAK2—lymphoid tissue—peritoneum cancer	0.00463	0.00463	CbGeAlD
Ruxolitinib—MAP3K2—female gonad—peritoneum cancer	0.00459	0.00459	CbGeAlD
Ruxolitinib—MAP3K7—female gonad—peritoneum cancer	0.00455	0.00455	CbGeAlD
Ruxolitinib—NUAK2—liver—peritoneum cancer	0.00453	0.00453	CbGeAlD
Ruxolitinib—TYK2—female gonad—peritoneum cancer	0.00447	0.00447	CbGeAlD
Ruxolitinib—IRAK1—female gonad—peritoneum cancer	0.00441	0.00441	CbGeAlD
Ruxolitinib—MKNK2—female gonad—peritoneum cancer	0.00441	0.00441	CbGeAlD
Ruxolitinib—JAK3—lymph node—peritoneum cancer	0.00437	0.00437	CbGeAlD
Ruxolitinib—TAOK3—uterus—peritoneum cancer	0.00437	0.00437	CbGeAlD
Ruxolitinib—JAK1—lymph node—peritoneum cancer	0.00434	0.00434	CbGeAlD
Ruxolitinib—DCLK1—lymph node—peritoneum cancer	0.00434	0.00434	CbGeAlD
Ruxolitinib—PLK4—lymph node—peritoneum cancer	0.00432	0.00432	CbGeAlD
Ruxolitinib—CAMK2G—liver—peritoneum cancer	0.00424	0.00424	CbGeAlD
Ruxolitinib—BMP2K—liver—peritoneum cancer	0.00424	0.00424	CbGeAlD
Ruxolitinib—CAMK1D—lymph node—peritoneum cancer	0.00424	0.00424	CbGeAlD
Ruxolitinib—PHKG2—lymph node—peritoneum cancer	0.00422	0.00422	CbGeAlD
Ruxolitinib—LRRK2—liver—peritoneum cancer	0.0042	0.0042	CbGeAlD
Ruxolitinib—DAPK2—lymph node—peritoneum cancer	0.00414	0.00414	CbGeAlD
Ruxolitinib—STK16—lymph node—peritoneum cancer	0.00408	0.00408	CbGeAlD
Ruxolitinib—TAOK3—lymphoid tissue—peritoneum cancer	0.00407	0.00407	CbGeAlD
Ruxolitinib—JAK2—female gonad—peritoneum cancer	0.00406	0.00406	CbGeAlD
Ruxolitinib—HIPK2—lymph node—peritoneum cancer	0.00406	0.00406	CbGeAlD
Ruxolitinib—MAP3K3—female gonad—peritoneum cancer	0.00392	0.00392	CbGeAlD
Ruxolitinib—DAPK3—lymph node—peritoneum cancer	0.0039	0.0039	CbGeAlD
Ruxolitinib—CLK2—lymph node—peritoneum cancer	0.00386	0.00386	CbGeAlD
Ruxolitinib—MAP3K2—liver—peritoneum cancer	0.00385	0.00385	CbGeAlD
Ruxolitinib—MAP3K7—liver—peritoneum cancer	0.00382	0.00382	CbGeAlD
Ruxolitinib—TYK2—liver—peritoneum cancer	0.00375	0.00375	CbGeAlD
Ruxolitinib—MKNK2—liver—peritoneum cancer	0.0037	0.0037	CbGeAlD
Ruxolitinib—IRAK1—liver—peritoneum cancer	0.0037	0.0037	CbGeAlD
Ruxolitinib—DYRK1A—lymph node—peritoneum cancer	0.00365	0.00365	CbGeAlD
Ruxolitinib—BMPR2—lymph node—peritoneum cancer	0.00363	0.00363	CbGeAlD
Ruxolitinib—TAOK3—female gonad—peritoneum cancer	0.00357	0.00357	CbGeAlD
Ruxolitinib—NUAK2—lymph node—peritoneum cancer	0.00347	0.00347	CbGeAlD
Ruxolitinib—JAK2—liver—peritoneum cancer	0.00341	0.00341	CbGeAlD
Ruxolitinib—MAP3K3—liver—peritoneum cancer	0.00328	0.00328	CbGeAlD
Ruxolitinib—CAMK2G—lymph node—peritoneum cancer	0.00325	0.00325	CbGeAlD
Ruxolitinib—BMP2K—lymph node—peritoneum cancer	0.00325	0.00325	CbGeAlD
Ruxolitinib—LRRK2—lymph node—peritoneum cancer	0.00322	0.00322	CbGeAlD
Ruxolitinib—TAOK3—liver—peritoneum cancer	0.00299	0.00299	CbGeAlD
Ruxolitinib—MAP3K2—lymph node—peritoneum cancer	0.00295	0.00295	CbGeAlD
Ruxolitinib—MAP3K7—lymph node—peritoneum cancer	0.00293	0.00293	CbGeAlD
Ruxolitinib—TYK2—lymph node—peritoneum cancer	0.00287	0.00287	CbGeAlD
Ruxolitinib—MKNK2—lymph node—peritoneum cancer	0.00283	0.00283	CbGeAlD
Ruxolitinib—IRAK1—lymph node—peritoneum cancer	0.00283	0.00283	CbGeAlD
Ruxolitinib—RET—lymph node—peritoneum cancer	0.00276	0.00276	CbGeAlD
Ruxolitinib—JAK2—lymph node—peritoneum cancer	0.00261	0.00261	CbGeAlD
Ruxolitinib—MAP3K3—lymph node—peritoneum cancer	0.00252	0.00252	CbGeAlD
Ruxolitinib—TAOK3—lymph node—peritoneum cancer	0.0023	0.0023	CbGeAlD
Ruxolitinib—CYP3A4—liver—peritoneum cancer	0.00091	0.00091	CbGeAlD
